2020
2 March, 2020
Karo Pharma completes the acquisition of product portfolio from LEO Pharma
Karo Pharma Aktiebolag (“Karo Pharma”) today announces that the acquisition of the intimate care and dermatology product portfolio from LEO…
19 February, 2020
Year-end report 2019
OCTOBER – DECEMBER · Net sales amounted to MSEK 649.3 (463.3). This corresponds to an increase of 40% for the…
4 February, 2020
Termination of Karo agreement with Pfizer
Karo Pharma AB (“Karo”) has been informed by Pfizer Inc. (“Pfizer”) about its decision to terminate the Research Collaboration and…